吉利德的Livdelzi®在原发性胆汁性胆管炎(PBC)中显示持续疗效,提供碱性磷酸酶(Alp)降低、缓解瘙痒及减缓疾病进展的潜力

美股速递
Nov 07, 2025

吉利德的Livdelzi®在原发性胆汁性胆管炎(PBC)中显示出持续的疗效,能够降低碱性磷酸酶(Alp)水平,缓解瘙痒感,并有潜力减缓疾病的进展。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10